Black Diamond Therapeutic...

NASDAQ: BDTX · Real-Time Price · USD
2.76
-0.03 (-1.08%)
At close: Aug 15, 2025, 3:59 PM
2.77
0.36%
After-hours: Aug 15, 2025, 07:30 PM EDT

Black Diamond Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
70M 70M n/a 4.89M 4.89M 4.89M 4.89M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 86K 172K 258K 1.08M 1.81M 2.53M 3.25M 3.24M 3.24M 3.24M 3.23M 3.05M 2.69M 2.22M 1.41M 787K 340K
Gross Profit
69.91M 69.83M -258K 4.55M 3.81M 3.09M 2.36M -3.25M -3.24M -3.24M -3.24M -3.23M -3.05M -2.69M -2.22M -1.41M -787K -340K
Operating Income
4.71M -4M -78.78M -81.36M -87.24M -85.14M -86.46M -87.46M -85.57M -88.71M -92.83M -97.06M -110.3M -121.84M -126.87M -123.97M -107.09M -87.4M
Interest Income
2.79M 2.14M 2.18M 1.94M 1.86M 1.94M 1.92M 2.28M 2.4M 2.25M 2.03M 1.94M 2.16M 2.72M 3.46M 4.13M 4.52M 4.45M
Pretax Income
14.44M 5.09M -69.68M -73.1M -80.55M -79.79M -82.44M -81.86M -80.51M -84.29M -88.92M -95.96M -109.38M -120.8M -125.6M -122.36M -105.19M -85.41M
Net Income
14.44M 5.09M -69.68M -73.1M -80.55M -79.79M -81.76M -79.4M -77.01M -80.16M -84.9M -93.72M -108.17M -120.22M -125.6M -122.36M -105.19M -85.41M
Selling & General & Admin
20.26M 25.73M 27.47M 27.06M 29.7M 27M 27.11M 28.79M 27.21M 27.31M 28.39M 27.56M 29.02M 30.04M 30.04M 29.05M 26.87M 23.73M
Research & Development
45.04M 48.19M 51.14M 54.05M 57.29M 57.97M 59.26M 58.67M 58.36M 61.4M 64.44M 69.49M 81.27M 91.8M 96.83M 94.92M 80.22M 63.67M
Other Expenses
n/a n/a n/a n/a 566K 907K 971K 1.09M 428K -56K -354K -844K -1.24M -1.68M -2.19M -1.81M -1.32M -740K
Operating Expenses
65.3M 73.92M 78.61M 81.1M 86.98M 84.97M 86.37M 87.46M 85.57M 88.71M 92.83M 97.06M 110.3M 121.84M 126.87M 123.97M 107.09M 87.4M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
51.88M 74M 78.78M 81.36M 87.24M 85.14M 86.46M 87.46M 85.57M 88.71M 92.83M 97.06M 110.3M 121.84M 126.87M 123.97M 107.09M 87.4M
Income Tax Expense
n/a n/a 42.72K 42.72K -72.28K -72.28K -801K -2.58M -3.5M -4.13M -4.02M -2.24M -1.21M -578K n/a n/a n/a n/a
Shares Outstanding (Basic)
56.8M 56.66M 56.61M 56.51M 55.16M 51.81M 51.64M 50.94M 36.52M 36.48M 36.39M 36.35M 36.29M 36.27M 36.23M 36.22M 36.18M 36.12M
Shares Outstanding (Diluted)
56.8M 57.67M 56.61M 56.51M 55.16M 51.81M 51.64M 50.94M 36.52M 36.48M 36.39M 36.35M 36.29M 36.27M 36.23M 36.22M 36.18M 36.12M
EPS (Basic)
0.25 0.08 -1.27 -1.37 -1.54 -1.7 -1.9 -1.99 -2.11 -2.2 -2.34 -2.58 -2.98 -3.32 -3.47 -3.39 -2.92 -2.38
EPS (Diluted)
0.23 0.06 -1.27 -1.37 -1.54 -1.7 -1.9 -1.99 -2.11 -2.2 -2.34 -2.58 -2.98 -3.32 -3.47 -3.39 -2.92 -2.38
EBITDA
4.96M -3.66M -78.44M -81.02M -86.98M -84.86M -86.14M -87.09M -85.08M -88.2M -92.32M -96.34M -109.66M -121.33M -126.47M -123.08M -105.46M -85.31M
EBIT
18.13M -4M -78.78M -81.36M -87.24M -85.14M -86.46M -87.46M -85.57M -88.71M -92.83M -96.84M -110.08M -121.63M -126.66M -123.42M -105.97M -85.82M
Depreciation & Amortization
258K 344K 343K 344K 1.08M 1.81M 2.53M 3.25M 3.24M 3.24M 3.24M 3.23M 3.05M 2.69M 2.22M 1.43M 816K 382K